13F

Stock

Quoin Pharmaceuticals, Ltd.

QNRX · held by 18 managers

Reported value

$12.2M

Holders

18

+1 new · −0 exited

Holders’ est. mark

Need a prior quarter

Largest holder

$3.05M

Ikarian Capital, LLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
Ikarian Capital, LLC211.5K$3.05MHeld
Woodline Partners LP79.6K$1.15MHeld
Stonepine Capital Management, LLC78.2K$1.13MHeld
Aberdeen Group plc75K$1.08MHeld
MILLENNIUM MANAGEMENT LLC74.8K$1.08MHeld
SummitTX Capital, L.P.64.8K$935KHeld
BOOTHBAY FUND MANAGEMENT, LLC59.8K$863.5KHeld
ADAR1 Capital Management, LLC58.2K$840.3KHeld
AIGH Capital Management LLC49.3K$711.7KHeld
Resolute Capital Asset Partners LLC30K$432.9KHeld
Soleus Capital Management, L.P.25K$360.8KHeld
Simplify Asset Management Inc.17.4K$251.8KHeld
Centiva Capital, LP12.1K$173.9KHeld
MORGAN STANLEY3K$43.3KNew
GAMMA Investing LLC2.08K$30.1KHeld
RHUMBLINE ADVISERS1.67K$24KHeld
SBI Securities Co., Ltd.247$3.56KHeld
UBS Group AG17$245Held

Positions as of Q4 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.